We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $412M
1-Year Est. Return 18.33%
This Fund
S&P 500
This Quarter Est. Return
+10.73%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$1.12B
AUM Growth
-$27.7M
Cap. Flow
-$120M
Cap. Flow %
-10.8%
Top 10 Hldgs %
27.63%
Holding
403
New
29
Increased
120
Reduced
176
Closed
26

Top Buys

Rank Stock Value
1
PGR icon
Progressive
PGR
+$10.1M
2
HUM icon
Humana
HUM
+$9.03M
3
ADM icon
Archer Daniels Midland
ADM
+$7.99M
4
TTC icon
Toro Company
TTC
+$7.78M
5
INTC icon
Intel
INTC
+$7.36M

Top Sells

Rank Stock Value
1
SMCI icon
Super Micro Computer
SMCI
+$24.5M
2
CTLT
CATALENT, INC.
CTLT
+$15.2M
3
MRK icon
Merck
MRK
+$12.3M
4
LLY icon
Eli Lilly
LLY
+$9.47M
5
LVS icon
Las Vegas Sands
LVS
+$9.43M

Sector Composition

Rank Sector Weight
1 Healthcare 32.63%
2 Consumer Staples 23.65%
3 Financials 11.73%
4 Technology 9.93%
5 Communication Services 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.02T
$33.9M 3.04%
43,604
-13,302
-23% -$9.47M
GIS icon
2
General Mills
GIS
$20.5B
$32.9M 2.95%
470,725
-24,876
-5% -$1.62M
ABBV icon
3
AbbVie
ABBV
$453B
$31.9M 2.86%
175,361
-43,386
-20% -$7.48M
CHD icon
4
Church & Dwight Co
CHD
$23.4B
$30.9M 2.77%
296,417
-6,566
-2% -$657K
MCK icon
5
McKesson
MCK
$106B
$30.6M 2.75%
57,063
-5,261
-8% -$2.67M
PGR icon
6
Progressive
PGR
$127B
$30M 2.69%
145,248
+54,354
+60% +$10.1M
CLX icon
7
Clorox
CLX
$11.3B
$29.8M 2.67%
194,540
-26,793
-12% -$4M
CBOE icon
8
Cboe Global Markets
CBOE
$31.2B
$29.6M 2.65%
161,122
+39,540
+33% +$7.3M
HUM icon
9
Humana
HUM
$48.2B
$29.5M 2.64%
84,942
+23,819
+39% +$9.03M
T icon
10
AT&T
T
$176B
$29.1M 2.61%
1,653,323
-45,999
-3% -$785K
SJM icon
11
J.M. Smucker
SJM
$13.5B
$28.2M 2.53%
224,000
-24,636
-10% -$3.12M
MRK icon
12
Merck
MRK
$371B
$27.5M 2.46%
208,346
-99,582
-32% -$12.3M
KR icon
13
Kroger
KR
$35.9B
$27.5M 2.46%
480,565
-94,848
-16% -$4.67M
NEM icon
14
Newmont
NEM
$135B
$25.9M 2.32%
721,794
+18,781
+3% +$647K
PFE icon
15
Pfizer
PFE
$162B
$25.2M 2.26%
908,042
+18,715
+2% +$519K
K
16
DELISTED
Kellanova
K
$25.1M 2.25%
437,482
-144,240
-25% -$7.94M
UTHR icon
17
United Therapeutics
UTHR
$20.9B
$25M 2.24%
108,647
-5,110
-4% -$1.15M
NBIX icon
18
Neurocrine Biosciences
NBIX
$15.8B
$24.6M 2.2%
178,253
-48,588
-21% -$6.64M
JNJ icon
19
Johnson & Johnson
JNJ
$663B
$24.1M 2.16%
152,093
-53,495
-26% -$8.51M
VZ icon
20
Verizon
VZ
$208B
$22.9M 2.05%
545,873
+7,920
+1% +$319K
SLB icon
21
SLB Ltd
SLB
$85.3B
$21.1M 1.89%
384,288
-16,993
-4% -$857K
ANET icon
22
Arista Networks
ANET
$244B
$20.8M 1.86%
286,656
-66,476
-19% -$4.48M
CPB icon
23
Campbell Soup
CPB
$6.38B
$20.2M 1.81%
454,302
-82,788
-15% -$3.58M
BMY icon
24
Bristol-Myers Squibb
BMY
$136B
$19.6M 1.76%
361,720
-170,184
-32% -$8.67M
DVA icon
25
DaVita
DVA
$11.7B
$16.1M 1.44%
116,735
-19,488
-14% -$2.34M
1
2 3 4 5

Similar funds

EC
EntryPoint Capital New York $412M AUM 28.52% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $412M AUM 24.95% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $412M AUM 26.77% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $412M AUM 34.27% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $412M AUM 57.16% 1-Year Est. Return
PA
Prism Advisors Studio City, California $412M AUM 20.58% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $412M AUM 26.77% 1-Year Est. Return

TOBAM's Q1 2024 Portfolio in Review

As of Q1 2024, TOBAM held 403 positions worth $1.12B, down 2.4% from $1.14B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

TOBAM withdrew a net $120M in Q1 2024, closing 26 positions and reducing 176 holdings. Its most notable exit was CATALENT, INC., an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 36% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, TOBAM opened a new position in Toro Company worth $7.73M.

  • TOBAM's largest Q1 2024 buy was Toro Company: 84,319 shares worth $7.73M.
  • TOBAM added most to Progressive in Q1 2024, an estimated $10.1M increase.
  • TOBAM's biggest Q1 2024 reduction was Super Micro Computer, cutting an estimated $24.5M.
  • TOBAM fully exited CATALENT, INC. in Q1 2024, selling an estimated $15.2M.
  • TOBAM's ten largest holdings make up 28% of its $1.12B portfolio in Q1 2024.
  • TOBAM opened 29 new positions and closed 26 in Q1 2024.
  • TOBAM's portfolio value fell 2.4% quarter-over-quarter to $1.12B.

Based on TOBAM's 13F filing for Q1 2024, filed 2 May 2024.